Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 09:59:33 2026-08-31 am EDT			5-day change	1st Jan Change
60.35 ^EUR	-0.82%		+1.25%	-4.57%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.61B		BBB
ELI LILLY AND COMPANY	1,047B		A
JOHNSON & JOHNSON	646B	-	BBB	-	-
ABBVIE INC.	451B		AA		-
ROCHE HOLDING AG	355B		AA
NOVARTIS AG	291B		AAA
ASTRAZENECA PLC	252B		A
AMGEN INC.	234B		A
NOVO NORDISK A/S	203B		A
GILEAD SCIENCES, INC.	181B		AA
PFIZER INC.	159B		A
VERTEX PHARMACEUTICALS INCORPORATED	137B		AA
BRISTOL-MYERS SQUIBB COMPANY	136B		A
SANOFI	107B		AA
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	72.33B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	57.89B		AA
BAYER AG	55.49B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	46.32B		AA
HALEON PLC	43.98B		AA
Average	228.98B		AA
Weighted average by Cap.			AA